Navigation Links
Hiemstra Appoints Robert C. Glines as Director of Business Development
Date:3/3/2008

Team expansion to ensure highest level of quality and customer satisfaction

SAN FRANCISCO, Calif., March 3 /PRNewswire/ -- Hiemstra Product Development, an innovative, product design and development company, serving the life sciences industry, today announced the appointment of Robert C. (Bo) Glines as Director of Business Development. As the company continues to expand and broaden its capabilities, Mr. Glines ensures quality, customized programs for each client.

Mr. Glines joins Hiemstra with over 20 years of technical, marketing, and business savvy from his experiences with life science Fortune 500 companies including Johnson & Johnson, Medtronic and Boston Scientific, and start-ups, such as CardioThoracic Systems (CTSI), Microheart, Inc., and AngioSense, Inc. He was part of the original, early-stage R&D team at CTSI, where he helped invent the platform technologies and continued through the IPO (which was one of the fastest IPO's of any medical device company). Mr. Glines co-founded Microheart, a needle-based drug delivery company, and founded AngioSense, a drug/device biotechnology venture in the field of gene therapy, where he raised an initial $4 million of financing. He has developed innovative medical technologies and worked with companies from inception to mature enterprises in clinical markets such as cardiac surgery, interventional cardiology, electrophysiology, gene therapy and drug delivery. Mr. Glines has 16 issued patents and numerous patent applications pending, and has coauthored several scientific and clinical publications.

"Today in the Med Tech sector, resource expansion is 'red hot!'," claims Glines. "Now with a 13485-certified clean room, our clients can leverage our infrastructure, experienced resources and CER to accelerate development of their products, from napkin sketch to commercialization." With his intimate knowledge of the medical technology sector, Mr. Glines brings a unique, focused vision as the company expands further down the outsourcing value chain.

Doug Hiemstra, President, stated, "Having known Bo for over ten years, as an associate and client, we believe that he is a perfect fit in our rapidly expanding organization. His breadth of clinical and technical knowledge and life sciences experience make him an asset to the Hiemstra team."

About Hiemstra:

Hiemstra Product Development is an innovative medical product design and development company. Founded in 1991, this San Francisco-based firm is built on its unparalleled integration of industrial and mechanical design, with a unique focus on usability and rapid commercialization. Hiemstra's veteran team's experience spans a broad range of clinical areas and applications, and clients include start-ups to Fortune 500 companies. A portfolio and description of services can be found at http://www.hiemstra.com.


'/>"/>
SOURCE Hiemstra Product Development
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):